Biomedical imaging techniques can provide a vast amount of anatomical information, enabling diagnosis and the monitoring of disease and treatment profile. MRI uniquely offers convenient, non-invasive, high resolution tomographic imaging. A considerable amount of effort has been invested, across several decades, in the design of non toxic paramagnetic contrast agents capable of enhancing positive MRI signal contrast. Recently, focus has shifted towards the development of agents capable of specifically reporting on their local biochemical environment, where a switch in image contrast is triggered by a specific stimulus/biochemical variable. Such an ability would not only strengthen diagnosis but also provide unique disease-specific biochemical insight. This feature article focuses on recent progress in the development of MRI contrast switching with molecular, macromolecular and nanoparticle-based agents.
Introduction
There exist a wide variety of spatially resolved clinical imaging modalities, including positron emission tomography (PET), computed tomography (CT), ultrasound, optical imaging and magnetic resonance imaging (MRI). 1 Of these, MRI stands out through its combination of convenient non-invasive application, high spatial resolution, and tomographic capability. This modality can provide images of the anatomy and physiology of living subjects by rapidly mapping out the spatial distribution of the proton ( 1 H) signal intensity. Originally termed nuclear magnetic resonance imaging upon its discovery in the 1940s (renamed MRI in the 1970s due to deemed negative connotations associated with the term 'nuclear'), this imaging technique works by exploiting the phenomenon of nuclear magnetic resonance (NMR) and, specifically, the reaction to a strong external magnetic field (B 0 ) of magnetic atomic nuclei, which absorb and re-emit electromagnetic waves at a characteristic radio frequency (RF). In a static magnetic field, nuclei process at a (Larmor) frequency (ω 0 ), which is linearly dependent on B 0 and the gyromagnetic ratio of the nucleus γ, according to eqn (1) . (1) The application of a RF pulse causes the net magnetisation vector associated with these processing and thermally equilibrated nuclei to flip from a position parallel to the external field to one transverse. The process of their relaxation back to the equilibrium state can occur by two different mechanisms, namely those which are longitudinal (or spin-lattice, T 1 ) or transverse (or spin-spin, T 2 ) in nature. An MR imaging system exploits the current generated by the motion of these relaxing magnetic moments by constructing a time domain NMR signal and using a Fourier transform to generate a frequency domain spectrum from which relaxation times may be derived. Images can be generated from these signals in different ways, most commonly by monitoring nuclear relaxation after a series of spaced RF pulses, which can then be spatially resolved electronically. Subsequently acquired image contrast in anatomical models is generated, in the first instance, from variance in water content across different body tissues. The inherently low sensitivity of MRI (arising primarily from the small energetic differential associated with nuclear Zeeman splitting) generally requires that this contrast be boosted through the use of added contrast agents, if it is to be diagnostically useful. Contrast agents work to enhance MR contrast by locally reducing T 1 and T 2 relaxation times. [2] [3] [4] [5] Those that predominantly reduce T 1 are referred to as "positive" contrast agents and result in increases in signal intensity (bright contrast), whereas those which primarily affect T 2 are commonly known as "negative", providing reductions in signal intensity (dark contrast). Clinically, T 1 agents offer higher spatial resolution and are not associated with false signal reading due to the existence of other signal draining sources in tissues that can plague T 2 modalities. The most common T 1 contrast agents currently used are paramagnetic gadolinium ion complexes (Gd 3+ ), due to their seven unpaired electrons, large magnetic moment and long electronic relaxation time (9-10 s), which contribute to enhanced relaxation according to the parameters set out in the Solomon, Bloembergen and Morgan (SBM) theory (vide infra). 6, 7 Free Gd 3+ , however, is toxic, disrupting physiological Ca 2+ signalling; 8, 9 kinetically robust chelation of Gd 3+ with ligands such as tetraazacyclododecane-tetraacetic acid (DOTA) is, thus, commonly employed. 10, 11 Such agents make up the majority of those in current clinical use, including gadopentetate dimeglumine (Magnevist), gadoterate meglumine (Dotarem), gadoteridol (ProHance) and gadodiamide (Omniscan). 12, 13 This article will focus on progress made in further engineering such Gd binding scaffolds so as to engender high image contrast with additional responsiveness to chemical or biological stimuli of physiological relevance.
Molecular contrast agents (CAs)
In order to enhance image contrast obtained from molecular T 1 agents (such as those listed above), optimisation of the parameters that govern relaxivity have been investigated in detail for several decades, most commonly with concurrent reference to the SBM theory. 3, 14, 15 Indeed, relaxivity (r 1 ), defined by eqn (2) , describing the change in relaxation rate (Δ(1/T 1 ) = ΔR 1 ) of water protons in the presence of a specified concentration of contrast agent ([CA]), is dependent on external field, temperature, the electronic properties of the paramagnetic centre, water residence time (τ m ), rotational correlation time (τ R ), first and second coordination sphere hydration (q), and the ion to water proton distance. 3 In general, enhanced relaxivity can be achieved by increasing the q value, shortening τ m and increasing τ R . (2) T 1 relaxation originates, in part, from dipolar interactions between the imaged water protons and local paramagnetic species. The former may be inner-sphere (IS, those directly coordinated to the Gd 3+ centre), second-sphere (SS, those hydrating the complex) or outersphere (OS, those diffusing near the chelate, governed by translational diffusion, τ D ), as depicted in Fig. 1 , with their relaxation rates contributing to the overall relaxation rate according to eqn (3) .
Inner-sphere contributions are thought to be the most important in the relaxation of molecular paramagnetic species (eqn (4) , where T 1m is the longitudinal water proton relaxation time) 16 and have hence dominated investigations where chelating ligand structure has been tuned to facilitate relaxation enhancement, 3, 6 or, more recently, report on immediate microenvironment. 3, 17, 18 (3) (4)
Responsive molecular contrast agents
In living organisms, variations in tissue and cellular microenvironment can provide vital information about the status of healthy or diseased tissues, organs and tumours. A specific sensitivity of MR image contrast to a physiological or biochemical reaction in tissue is the main focus of the emerging discipline of functional MRI. 19 The most well-known example of this is blood-oxygen-level-dependent (BOLD) contrast, which depicts differences in blood oxygenation related to neural activity. 20 This technique provides MR contrast change through the imaging of haemoglobin (Hb) and the extreme sensitivity of this to oxygenation (an accompanying transformation of Hb from paramagnetic to diamagnetic).
The most common method of facilitating an MRI contrast response to environment with lanthanide macrocycles is through variations in hydration state (q value), often facilitated by conformation change. 16, 21 The second-sphere water molecule dynamics of a chelate can also be manipulated by an environmental trigger, providing variation in MRI signal contrast. [22] [23] [24] [25] Responsive conformation changes can alternatively result in a change in contrast agent molecular volume, affecting τ R and hence T 1m . 26 Increases in the molecular weight of a contrast agent, through cross-linking or polymerisation, can also be prompted by an environmental stimulus, resulting in image contrast enhancement through the reduction of molecular tumbling rates (increasing τ R ). It is worth noting here that, in the design of agents for conventional MRI, permanent enhancement of signal contrast is the desired goal; in functional MRI, specific change in response to a physiological trigger (and the degree and specificity of relaxivity change) is more important than the absolute magnitude.
Bio-responsive molecular contrast agents
Potentially the most important developing class of responsive MRI is that based on agents that are acted on by pathologically relevant enzymes such as those associated with disease states including stroke, cerebral ischemia, cardiovascular or neurodegenerative inflammatory processes. 27 Pioneering work by Meade and co-workers in the late 1990s, for example, paved the way towards the development of responsive or 'smart' MRI contrast agents specifically designed to respond to an enzymatic cleavage. 28 Their work describes a family of 4,7,10-tri(acetic acid)-1-(2-β-galactopyranosylethoxy)-1,4,7,10-tetraazacyclododecane gadolinium (EGad) contrast agents, whose galactopyranose groups are removed by β-galactosidase (an important reporter marker for monitoring gene expression), resulting in an irreversible transition from a weak to a strong relaxivity state. A 20% change in relaxation rate is observed through the removal of a H 2 O blocking group, increasing q and, thus, improving inner sphere T 1 relaxation (Fig. 2 ). Since then, several similar approaches have been published describing the modulation of MRI contrast through the control of water access to a chelated paramagnetic centre. [29] [30] [31] These have achieved 3-fold increases in relaxation rate upon enzymatic cleavage of the hydration-hindering group. 29 An alternative approach has been offered by Giardiello et al., who prepared a neutral complex that binds with high affinity to H 2 O-blocking HCO 3 − anions and displays low relaxivity. The action of a specific enzyme (porcine liver esterase) on the modified side arms of this DOTA derivative introduces new anionic charge, repels the chelating HCO 3 − ions increases metal hydration, and triggers a ~90% increase in signal contrast. 32 Reliance on inner sphere hydration as the mechanism of MRI contrast modulation, however, is not ideal. Anion interactions with the cleaved (more solvated/accessible) paramagnetic species, has, in particular, been identified to be a considerable interfering factor, particularly in vivo, where water-competing anions are abundant. 30 Such interactions can have a significant detrimental effect on resulting relaxivity and any assumptions therein; alternative mechanisms to achieve MRI activation have, therefore, been investigated.
One such mechanism is the so-called receptor-induced magnetisation effect (RIME), which utilises binding of a target moiety, such as a protein, to a paramagnetic chelate, resulting in the formation of a bulky, slow-tumbling macromolecular contrast agent with increased τ R (and thus relaxation/contrast relative to background; Fig. 3 ). 33 In this vein, Breckwoldt et al. have employed a bis-5-hydroxytryptamide-diethylenetriamine-pentatacetate gadolinium species, which, in the presence of the enzyme myeloperoxidase (MPO, a key enzyme secreted in the inflammatory response to tissue injury), oxidises and radicalises, leading to cross-linking, polymerisation and subsequent protein binding. 27 Successful triggering of relaxation enhancement was non-invasively monitored in vivo, allowing tracking of MPO activity in stroke-affected mice models. A Gd 3+ -diethylenetriaminepentaacetic acid (DTPA) type construct with a phosphonate side-chain, termed MS-325 by Caravan et al., which targets human serum albumin (HSA), again employs the RIME strategy to provide selective vascular MRI enhancement. In this case, HSA binding limits extravasation of the free chelate from the blood pool into the non-vascular space, slowing renal excretion and contributing to an extended blood half-life and also thus providing vascular-specific relaxation rate enhancement. A 9-fold increase in relaxivity (at 20 MHz) was observed upon non-covalent HSA binding in ex situ studies, due to slowing molecular rotation (τ R ) of the HSA-bound MS-325 entity. 33 A similar strategy employs a Gd 3+ -chelate functionalised with a trilysine masking group with associated poor native HSA affinity (and hence low relaxivity, r 1 = 9.8 mM −1 s −1 at 20 MHz, 37 °C). Upon cleavage of the lysine residues by human carboxy peptidase B, a thrombin-activatable fibrinolysis inhibitor (TAFI, an important enzyme in thrombotic disease), the chelate-HSA affinity increases substantially due to the exposure of aryl groups with high HSA binding affinity, a transition with an associated 170% relaxivity enhancement (to 26.5 mM −1 s −1 at 20 MHz, 37 °C). 34 Sherry and co-workers have designed a Gd-DO3A-peptide-based CA that is τ R activated upon binding to a specific target protein in a similar vein. 35 The relaxivity of this CA (r 1 = 8. 36 The degree of relaxivity switching, however, was adversely affected by the displacement of inner sphere water molecules by carboxylate residues of the protein, an inherent problem often observed in the presence of oxygen-based chelates.
The vast array of diagnostically potent functional enzymes and proteins present physiologically makes this class of bioresponsive CAs arguably the most important in detecting and monitoring disease pathology. The examples of bio-responsive switchable CAs referred to herein represent some of the most effective (in terms of the degree of switching) of this class so far available and exploit robust change in q or τ R . It should be highlighted, however, that the majority of these cases present irreversible changes in contrast, with a 'one-off' trigger facilitating the contrast enhancement or reduction. Further work will be required to generate derived CAs capable of long-term use or disease treatment profiling.
Cation responsive molecular contrast agents
Another important class of biologically activatable CAs are those which can be triggered by the presence of metal ions. Metal ions are vital in a variety of physiological pathways. Ca 2+ ions for example, play an important role in neural signalling and changes in brain activity can lead to variations in its concentration. Similarly, increased Zn 2+ ion concentrations have been implicated in environments commonly associated with Alzheimer's disease. 37 Cation responsive contrast would therefore undoubtedly be diagnostically potent. 38 In the design of such, signal changes are once again most commonly effected through variance in hydration number of paramagnetic CA complexes. There have been several examples exploiting this in recent literature, most of which employ conformation changes and associated perturbations in inner-sphere water access and q. The first reports of a Zn 2+ -specific CA reporter were by Hanaoka et al., who described DTPA-bisamide chelators which respond sensitively and selectively to Zn 2+ through the displacement of inner sphere water arising from a Zn 2+ binding induced geometrical reconfiguration. 39, 40 Such systems observed a ~33% decrease in relaxivity due to the inhibition of water access to the Gd 3+ -chelator upon cation binding. Gadolinium complexes with bis-15-crown-5 ether or β-diketone recognition sites have also been prepared to enable the detection of K + , Mg 2+ or Ca 2+ ions, with MRI signal contrast again decreasing due to a geometrical rearrangement in the presence of the metal ion, and associated change in the second sphere of paramagnet hydration. 41 Within this study, the most efficient MRI response was observed for β-diketone tethered Gd-DTPA species, whose r 1 relaxivity (4. 42 These changes were attributed to an increase in water exchange rate upon ion binding, or alternatively, the creation of a more organised second sphere of water molecules (bound to the Zn 2+ or Cu 2+ ions) in close proximity to the single Gd 3+ -bound water molecules of the complex. This group has recently improved upon this by using a Gd-DOTA derivative containing two bis-(3-pyrazolyl) units, yielding a 64% relaxivity enhancement with introduction of Zn 2+ ions, also demonstrating successful in vivo application. 43 Interestingly, these groups also describe significant further r 1 relaxation enhancement of the Zn 2+ -coordinated complex upon binding to human serum albumin (HSA), providing a 165% increase (from 6.6 to 17.4 mM −1 s −1 ), a rotational correlation time (τ R ) effect only occurring in the presence of the metal ions. 42 Major et al. have demonstrated that the design of the chelate species can play a vitally important role in relaxivity modulation by specific cations. 44, 45 Their asymmetric chelates display an acetate pendant arm capable of switching its coordination to either the paramagnetic centre of the contrast agent or a cation, such as Zn 2+ . Coordination to the former centre generates a coordinatively saturated chelate, with q = 0 and hence low MRI contrast. Coordination to a Zn 2+ ion causes a change in the molecular geometry and the Gd 3+ coordination sphere, leading to an increase in hydration number to q = 1 (Fig. 4) , and 121% increase in r 1 relaxivity (from r 1 = 2.3 to 5.1 mM −1 s −1 at 60 MHz). Subsequent in vitro studies demonstrated a qualitative increase in T 1 -weighted image contrast of the agent in the presence of physiologically relevant concentrations of Zn 2+ . 44 Specificity amongst metal ions can, of course, be an important factor for consideration in the design of metal ion-modulating MRI contrast. Gd-chelates have been designed to recognise various different metal ions, including Cu 2+ , Ca 2+ , Mg 2+ and K + with selectivities generally utilising Irving-Williams governed trends in affinity as well as coordination environment preferences. 46 Ethylene glycol tetraacetic acid (EGTA, a highly selective Ca 2+ chelator) has, for example, been bound to two macrocyclic Gd 3+ -containing moieties, with Ca 2+ ion binding causing increases in the inner-sphere hydration number of the chelate and concomitant modest associated protic longitudinal relaxivity increases (32% from r 1 = 5.4 to 7.1 mM −1 s −1 at 500 MHz). 46 Similar constructs exploiting q to effect a contrast change have shown 83% increases in relaxivity in the presence of Ca 2+ (from r 1 = 3.4 to 6.3 mM −1 s −1 at 500 MHz); at physiological concentrations, such as those in the relevant range for Ca 2+ modulation in the brain (0.8-1.2 mM), relaxivity changes of ~10% are observed. 47 Similarly, DOPTA-Gd complexes structurally modulate inner-sphere water access to the chelated Gd 3+ ion using iminoacetate arms, which shield the paramagnetic centres from water in the absence of Ca 2+ ions (q = 0). 48 Upon binding of Ca 2+ , the complex undergoes a reorganisation leading to an increase in q and relaxivity by 80% to 5.8 mM −1 s −1 (at 500 MHz) over Ca 2+ concentrations ranging 0.1-10 μM. Cu + /Cu 2+ ion selectivity has been achieved by Que et al. through the design of Gd-DO3A chelates coupled to acetate or thioether-rich receptor ligands, which rely upon modest q modulation through Cu 2+ binding (eliciting a 40% change in relaxivity). 49, 50 Similarly, Pope and co-workers use a bismacrocylic ligand which recognises Hg 2+ to generate a 24% increase in relaxivity. 51 The highest increase in longitudinal MRI relaxation exploiting a hydration change mechanism has been observed for thioether-tethered DO3A chelates, demonstrating a 360% increase in r 1 upon binding 1 equivalent of Cu 2+ (from 1.5 to 6.9 mM −1 s −1 at 20 MHz). 50 The initially low r 1 observed in the absence of metal ions in this work is suggestive of a q = 0, with the acetate or pyridine moieties present on the linker initially capping inner-sphere water access (a cap that is removed on the association of Cu 2+ ions; Fig. 5 ). A polyarginine modified version of this chelate has demonstrated some promise in initial intracellular work. 52 Recently, several others have reported a variety of Gd-DOTA-based chelates with pendant arms capable of cation binding, providing relaxivity responses due to q modulation. [53] [54] [55] Modulation of MRI contrast based on metal ion recognition by a CA can also be achieved through exploitation of rotational correlation time. Peters and co-workers have investigated bisphosphonate appended coordination oligomers of a DOTA-like chelator as a means of generating cation triggered changes in rotational correlation time. 56 This resulted in 200-500% increases in r 1 (depending on Zn 2+ concentration), although it was noted that selectivity would be poor under physiological conditions. A 250% relaxivity enhancement of Gd-DOTA-diBPEN in response to Zn 2+ ions has recently been translated reasonably well to both ex vivo and in vivo studies, an effect which relies upon binding of the Zn 2+ -bound-chelate species to HSA and resulting changes in τ R . 57 Several groups have investigated heterometallic complexes featuring Gd-chelates which self-assemble to form bulky macromolecules upon coordination to iron ions. [58] [59] [60] [61] Comblin et al., for example, have designed a Gd(phen)HDO3A chelate (r 1 = 3.7 mM −1 s −1 at 20 MHz) which uses its phenanthroline-like unit to complex Fe 2+ ions, forming a tris-complex with very high molecular weight, with an associated relaxivity increase to 12.2 mM −1 s −1 . 11 Toth and coworkers have developed a metallostar structure comprising six densely packed Gd 3+ -diethylenetriaminetetraacetic acid (DTTA) chelates around an Fe 2+ ion, resulting in an almost 2-fold increase in relaxivity (from 12.4 to 20.2 mM −1 s −1 at 20 MHz). 59 The formation of slowly rotating macromolecular species with increased τ R is responsible for the observed enhancements throughout all these works. An alternative method for metal ion detection employing relaxivity responses which has been explored by Muller et al. describes the transmetallation of a DTPA-derived chelate (MS-325) which releases Gd 3+ into solution in the presence of Zn 2+ ions, resulting in insoluble Gd-phosphate complexes which precipitate and hence no longer contribute to the observed 1 H r 1 relaxivity. 62 This process leads to a 25% reduction in r 1 after 5000 min. The timescale and associated toxicity risk of this method, however, is unlikely to make it practically relevant.
There have been, then, a number of reported approaches to tune r 1 relaxation through association with physiologically relevant levels of cations. In nearly all cases this has been through the modulation of water access or rotational correlation time and accompanied by varying degrees of relaxivity switching (20-360%). Bar some obvious exceptions, performance is both modest and detrimentally affected in attempts to extrapolate to physiological in vivo conditions. Though much work clearly remains to be done, particularly in safeguarding specificity, these prior reports show promise and are likely to underpin future developments.
pH-responsive molecular contrast agents
MRI contrast agents capable of detecting variations in environmental pH can be of particular use for the non-invasive detection of disease or metabolic disorder. 63 Ischemia, for example, is often defined by low pH (caused by amide exchange due to regional neural ischemia, for instance) and can characterise heart disease. Similarly, regions of acidity can indicate the presence of hypoxia, tumour growth and metastases (malignant tumours present with pHs ranging from 6.8-7.2). 64 pH reporters can hence provide important information which can impact directly upon selected treatment (e.g. hypoxic tumour cells are resistant to radiation and to many anticancer drugs 65 ) and a monitoring of their efficacy. It is unsurprising then that a range of paramagnetic agents have been developed in which hydration state, leading to either increases or decreases in signal, is highly pH dependent.
Pagliarin and co-workers have, for example, described a series of Ln 3+ macrocyclic complexes in which the presence of a β-arylsulfonamide group on the chelate species supports pH dependent relaxivity (as well as luminescence). 16 These systems are based on protonation of the sulphonamide nitrogen and the associated increase from q = 0 to q = 1 (with a 48% increase in r 1 relaxivity values over the pH range 7.4-6.8 and concomitant decrease in photoluminescent emissivity due to water based quenching). Hall et al. have synthesised terpyridine-based Gd 3+ -chelates which demonstrate decreasing relaxivities with increasing pH (from r 1 = 12.8 mM −1 s −1 at pH 6 to r 1 = 2 mM −1 s −1 at pH 11, at 20 MHz), attributed to an overall decrease in q from 3 to 0, due to the successive deprotonation of water molecules and subsequent formation of dimeric complexes possessing no bound water molecules. 66 An alternative approach to pH modulation of MRI is to exploit proton exchange between inner sphere coordinated water molecules and bulk water due to highly acidic/basic environments. This approach has been employed by Aime et al., who have described a range of C 4 -symmetric Gd 3+ -DOTA-type chelates with different pendent arms demonstrating largely invariant relaxivity between pH 2-8 (where r 1 ≈ 2.5 mM −1 s −1 at 20 MHz, due to only outer-sphere contributions), but marked increases in r 1 at very high (>10; r 1 ≈ 5.7 mM −1 s −1 at 20 MHz) and very low (<2; r 1 ≈ 5 mM −1 s −1 at 20 MHz) pH environments. 22, 23 The observed increases in relaxation behaviour at these two extremes are attributed to the formation of a well-defined second hydration sphere, where water molecules are in rapid exchange. In strongly basic media this is ascribed to deprotonation of bound water molecules or proximate ligand amide NH protons. In acidic media these beneficial changes are ascribed to protic-catalysed dissociation of the ion-paired water-Gd-complexes, promoting water exchange. Similar work by Sherry and co-workers has described Gd 3+ -DOTA complexes with phosphonate pendent arms with strong pHdependent r 1 behaviour, demonstrating two relaxivity troughs, the first having a 40% variation between pH 2-6 and 70% between pH 6-12, with an r 1 maximum at pH 6, observations again ascribed to protic exchange between bound water protons and bulk solvent protons contributing to a second hydration sphere possessing rapidly exchanging water molecules. 24, 25 A major limitation inherent in the field of responsive contrast lies in the lack of ability to quantify the concentration of contrast agent present at the site of interest (meaning, in turn, that relaxivities resulting from any trigger can only be qualitative). There is, then, much interest in the development of ratiometric responsive CAs and most development thus far has been associated with those which respond to local pH. Sherry and co-workers have, for example, investigated such a system (employing a mixture of pH-insensitive GdDOTP 5− and pH sensitive GdDOTA-4AmP 5− chelates with necessary assumptions about identical biodistribution) and demonstrated its efficacy both in vitro and in vivo. 17, 67 An alternative approach is to measure the ratio between the transverse and longitudinal paramagnetic relaxation rates of water protons in response to a single contrast agent (R 2 /R 1 ), as described by Terreno and co-workers. 68 This approach, based on a Gd 3+ -complex having τ m or rotational mobility dependent on pH, allows an assessment which is independent of contrast agent concentration. Bimodal agents employing a second imaging technique using a dualfunctional probe can also provide quantification of local contrast agent concentration and hence relaxivity, 69 an approach adopted in work by Frullano et al., which saw the production of a dual MRI-PET agent composed of the pH-dependent GdDOTA-4AMP chelate appended with a 18/19 F functionality. 70 A linear relationship between the PET and MRI signals allowed determination of the concentration of the agent through comparison with a pH calibration curve, providing a quantitatively accurate non-invasive probe of great promise for in vivo application.
To summarise thus far, the most common and controllable approach to effect relaxation change by pH modulation is through exploitation of the hydration state (q) of molecular contrast agents. In this way, enhancement or reduction of signal contrast can be attained, with modest (up to 70%) changes over relevant physiological pH ranges (pH 6-8). 24 The use of protic exchange and second hydration sphere dynamics can provide an alternative pH responsive route to MRI contrast modulation, although the most significant responses occur at very high (>10) or very low (<2) pH regions, making such responses less physiologically relevant. To allow unambiguous assessment of MRI contrast modulation, the contrast agent concentration must be accurately known, a particularly difficult prospect in site-targeting and in vivo applications. Responsive ratiometric contrast agents offer great potential in this area and some initial investigations have demonstrated promise.
Redox responsive molecular contrast agents
Redox reactions are widespread in biochemical systems, with organisms integrating them directly within fundamental methods of energy generation. A change in oxidising/reducing condition can result from variations in blood flow, oxygenation and other variables and can have a profound effect on physiological function, such as those in the brain accompanying stroke, Parkinson's and Alzheimer's diseases. 71 Very often such physiological stress is associated with increased reactive oxygen species (ROS) and decreased antioxidant levels. 72, 73 One can seek to directly acquire tomographic mapping of such conditions through the use of paramagnetic agents which are, in some capacity, redox active.
One non-metallic class of such are the nitroxides, which undergo reduction to diamagnetic hydroxylamines, resulting in a marked and reversible contrast change. 71, 73 These aside, T 1 -weighted contrast agents demonstrating redox triggered contrast switching are rare. [74] [75] [76] Louie and co-workers have described the only Gd 3+ -based T 1 -contrast agents capable of redox sensing using a Gd 3+ -DOTA system featuring a spiropyran/merocyanine motif, demonstrating 26% relaxivity decreases upon redox activation (from 2.5 to 1.9 mM −1 s −1 at 60 MHz), caused by decreasing hydration number (from q = 1.16 to 0.44) as a result of a conformation change. 74, 75 An 8-coordinate chelate complex tethered with acyclic merocyanine converts to its spirocyclic isomer, a 7-coordinate chelate, following reduction using nicotinamide adenine dinucleotide (NADH). This structural change increases the hydration number of the complex (from q = 1 to q = 2), resulting in a 54% increase in relaxivity; a change which is reversible upon treatment with hydrogen peroxide (Fig. 6) . 74 A slightly different mechanistic approach has also been explored towards the development of redox switchable CAs sensitive to environmental O 2 partial pressure (pO 2 , which is relevant in various pathological diseases, including stroke and tumours), exploiting variations in the chelate metal centre oxidation state, similar to the BOLD method of activated detection earlier described. 77 In this vein, Terreno and co-workers have investigated manganese (Mn 2+/3+ ) porphyrin complexes which were encapsulated into cyclodextrin (CD) hosts. 78 Though there exist, then, a number of elegant examples of redox responsive MR contrast which have been applied in vitro, it is clear that much more work needs to be done before the realisation of reliable and marked switching of signal contrast in vivo.
Light responsive molecular contrast agents
Bioluminescence imaging is a useful non-invasive modality providing potentially excellent signal-to-noise, spatial refinement and high throughput. Although poor tissue penetration makes it a less tractable means of switching contrast than other methods noted thus far, light emitting gene markers, such as those based on lucerase-luciferin could potentially provide an appropriate application for photoactivatable agents. 21, 82 To this end, a small number of articles have hence described the development of light-sensitive MRI contrast agents based Davies et al. Page 10 on spirobenzopyrans, which undergo an isomeric conformation change upon light irradiation, affecting water coordination (q) at the paramagnetic metal centre. 21, 75 This transformation (which is reversible) prevents hydration at the metal centre, resulting in a reduction in relaxivity of about 21% (from r 1 = 3.7 mM −1 s −1 to 2.9 mM −1 s −1 at 60 MHz). 75 Though modest, this work may find application if, for example, larger relaxivity changes can be married with NiR wavelength triggering.
Macromolecular and nanoparticle contrast agents
Small molecule CAs have paved the way for enhanced medical imaging (including that which is targeted and/or multimodal), and facilitated most of what we understand in terms of tuning CA behaviour in vitro and in vivo. However, their limitations, in particular rapid elimination, and the quest for signal amplification, have resulted in the increased utilisation of higher molecular weight species offering inherently striking and, in many cases, profoundly advantageous characteristics. 13 Relaxivity can be improved by the incorporation of paramagnetic gadolinium centres directly into a nanosized matrix to obtain, for example, GdF 3 :CeF 3 nanoaggregates coated with poly(acrylic acid) chains, 83 doped zeolite GdNaY, 84 gadofullerenes, 85 gadonanotubes, 86 GdF 3 :citrate, 87 or PEG-phosphate coated NaGdF 4 nanoparticles. 88 Though a number of these derivations are associated with high MR contrast, they very often exhibit low kinetic stability and hence potentially high levels of toxicity. A preferred method of increasing signal contrast is by embedding or conjugating numerous clinically approved Gd 3+ -chelates to macromolecules or nanoparticulates based on polymers, 89 dendrimers, 90 liposomes, 91 micelles, 92 proteins, 93 virus capsids, 94 gold glyconanoparticles, 95 or silica. 96 These approaches primarily exploit the inherently large particle surface area and size to improve MRI signal. Before looking at some of the characteristics associated with the paramagnetic modification of such species, we briefly review the mechanisms associated with the dipole-dipole longitudinal relaxation mechanism. As outlined earlier (eqn (3) and (4)), inner-sphere contributions generally dominate relaxation enhancement. The longitudinal relaxation rate of the bound water (1/T 1m ) is given by eqn (5). These expressions confirm that the relaxation behaviour of a complex depends on a number of parameters, including the distance between the unpaired electron spin of Gd 3+ and protons of the coordinated H 2 O (r Gdh ), the angular proton Larmor frequency (ω I ) and the global and local correlation times (τ CG and τ CL , respectively, defined by eqn (6) and (7)).
Davies et al. Page 11 where μ 0 is the permeability of vacuum (μ 0 = 1.257 × 10 −6 N A −2 ), γ I is the gyromagnetic constant for protons (γ I = 2.675 × 10 8 T −1 s −1 ), g is the electronic g-factor (g = 2), μ B is the Bohr magneton (μ B = 9.274 × 10 −24 J T −1 ), S is the total electron spin of the material ion (S = 7/2 for Gd 3+ ), F 2 denotes the order parameter (vide infra) and T 1e is the electron spin longitudinal relaxation time. 97 As a result of the natively increased steric bulk of nanoparticles or macromolecules, tumbling of the appended molecular paramagnetic probe is, relatively, slowed down; the associated increase in overall rotational correlation time (τ R ) providing concurrent improvement of relaxivity. 98 The length of τ R for small molecular weight Gd 3+ -chelates is in the picosecond range (50-200 ps), 99 1-3 orders smaller than τ m and T 1e , and so τ C is dominated by τ R . 100 On the other hand, τ R of their higher molecular weight counterparts is in the nanosecond range (0.5-50 ns), a timescale which is comparable or even longer than τ m and T 1e . Since eqn (4) predicts a higher relaxivity for a shorter τ m value (τ m << T 1m ) and T 1m can already be more than one order of magnitude shorter in such systems (eqn (5) and (6)), the relaxivity of nanoparticulate contrast agents is characteristically limited by rather long τ m and thus slow k ex (k ex = 1/τ m ). 97 An important consideration in the design of macromolecular or nanoparticulate CAs with high relaxivity is the structure and flexibility of the linking moiety (it is not necessarily the case that the particle structural rigidity and rotational time are directly translated to appended complexes). Fast rotation around the Gd 3+ -complex linker compared to the motion of the nanoparticle can be a limiting factor in the relaxivity enhancement; if Gd 3+ -complexes are covalently attached to the surface of the particle through a flexible linker, their local rotational motion (τ RL ) around the axis of the linker in solution is much faster than the global rotation of the nanoparticles (τ RG ) (Fig. 7) . Using the Lipari-Szabo approach 85, 86 incorporated into the SBM equations, the relaxation parameters of nanoparticulate MRI probes can be obtained through fitting of experimental nuclear magnetic resonance dispersion (NMRD) profiles. 101 The degree of spatial restriction of the motion, i.e., the extent to which τ RL and τ RG contribute to τ R is described by the order parameter F 2 (0 ≤ F 2 ≥ 1). If τ RL is negligible, as in a perfectly rigid system, F 2 equals 1. In more conformationally flexible environments, F 2 approaches 0, and internal motions are completely independent of global motion. 96 These nanoscale effects are summarised in eqn (5), which is valid at B 0 > 1.5 T if the global molecular reorientation is isotropic. 3, 97 This theoretical framework enables evaluation of the rigidity and the internal motions of the nanosized system, the influence of the length and flexibility of the contrast agent linker on the relaxation parameters, and the contributions emerging from both the appended molecular MRI probe and from the nanoparticle to the overall relaxation of the composite. 102 The number of nanoparticulate-based MRI contrast agents has rapidly increased in recent years, due not only to their capacity to deliver a large number of paramagnetic ions per nanostructure, allowing improvements in relaxivity per unit dose compared to individual Gd 3+ -chelates, but especially, as noted, due to their ability to boost relaxivity by retarding the chelate tumbling rate. 98 The conjugation of Gd 3+ -chelates to block, graft, or micellar macromolecular carriers generates a class of CA whose relaxivity is dependent on the polymer rigidity. 90, 103 This, in turn, is chemically tuneable through the overall molecular weight, 104 by the incorporation of monomers with high glass transition temperatures, 105 by grafting of conjugated polymers possessing a more rigid backbone, 106 enhancing the degree of cross-linking, 107 lengthening and making side chains hydrophobic, 102 or by increasing the number of internal hydrogen bonds (and hence reducing internal motion). 90 Improved H 2 O exchange can be achieved by the incorporation of a hydrophilic shell layer that serves as a reservoir for water molecules. 108 On the other hand, grafting polyethyleneglycol (PEG) chains onto hyperbranched polymers and dendrimers is known to slightly decrease relaxivity because of hindered water exchange. 103, 109 In dendrimers, relaxivity can be maximised with each increase in branching generation, through τ R effects. This trend, however, is not exhaustive and has been found to decrease once the G9 generation is reached. 13 Macromolecular formulations with an MRI sensitivity that is environmentally responsive in a simple manner can be achieved by selecting monomers with responsive functional groups, 110 by gating the water accessibility, 111 by conformational conversion between globular and extended form, 107 through the incorporation of cleavable linkers, 103 and by switching between hydrophobic interaction and electrostatic repulsion, 112 amongst others.
Cone-like or truncated cone-like amphiphiles that self-aggregate into micelles or liposomes under specific conditions have also been utilised to improve CA relaxivity. 13, 97 Memsomes (Fig. 8 ) are a class of liposomes, where a paramagnetic complex can be attached to the hydrophilic heads of the lipid molecules in the bilayer, allowing easy access to solvent. 13 In this case, the attachment of the paramagnetic complex to the membrane is not rigid (τ RL << τ RG ), and so the size of the memsome itself has no effect on relaxivity. 113 Instead, the latter is observed to be dependent on the rotational diffusion of the Gd 3+ -complex on the surface of the liposome, 114 as well as on the length of the linker, tuning water accessibility to the lanthanide CA centre. 115 On increasing the alkyl chain length from C10 to C18, τ RG can increase from 500 to 2800 ps. However, the advantage of high τ RG is reduced in all liposomal systems due to the high internal mobility of the Gd 3+ -complexes (short τ RL and low F 2 ), and slow k ex . 102 The latter is highly dependent on the phospholipid membrane's water permeability in enosomes, which comprise a group of liposomes that encapsulate water-soluble Gd 3+ -chelates. 97 Enhancement of the permeability concomitant with a shortened τ io (i.e. water exchange time between internal, i, and external, o, parts of the liposome) 116 can be achieved by increasing the temperature towards the phase transition temperature (T M ) that causes phospholipids to undergo a gradual increase in fluidity. In this system, quenched r 1 can only be recovered when the liposome composition allows for rapid water exchange between the interior and exterior of the enosomes (τ io << T 1i ). Subsequently, relaxivity of the paramagnetic agent encapsulated within the liposome becomes similar to that in the solution. Higher concentrations of metal chelate encapsulated within the liposome and higher internal viscosity, further lengthens the rotational and diffusional correlation times, contributes to a slightly higher relaxivity compared to nonencapsulated Gd 3+ -complex. 91, 116 Another important class of highly tuneable nanoparticulate CAs consists of inorganic biocompatible Gd 3+ -chelate decorated mesoporous silica nanoparticles (MSNs) with uniform mesopore compartments and large silanol surface areas. 94, 117, 118 The geometric confinement of the former increases τ R of the paramagnetic complex and τ D of water molecules (increasing the H 2 O-lanthanide interaction time) and, through this, relaxivity. 85, 119 The tuneable surface chemistry can be further exploited to improve the accessibility of water and increase the water-exchange rate, k ex . For example, a threefold faster k ex was reported after acetylation of surface amine groups otherwise used for conjugation to Gd 3+ -chelates. 120 It is clear, then, that nanostructured and macromolecular materials can provide improved MRI signal contrast due to their behaviour in suspension. Such materials can be further engineered to offer stimuli responsive contrast in a predictable and useful manner. Their characteristics can be tuned through design and synthesis in terms of q, 121 τ RL , 122 τ RG , 89 , τ io 123 or τ m , 114 and have the capability to additionally provide specificity to a site of interest, high in vivo mobility, and multimodality as well as multifunctionality. As such, they represent an increasingly important class of MRI contrast agent.
pH-responsive particulate contrast agents
Nanoparticulate MRI probes can be designed to exhibit significant contrast response to physiological or pathological pH change in the region of interest. 124 Most typically, this is through the incorporation of pH-responsive Gd 3+ -chelates, 125 acid labile linkers such as ketals 126 or pH-responsive groups into a nanoparticle scaffold, 127 whose pH-responsiveness triggers a global response across the particle, such as a change in hydration state (leading to swelling/collapse), propensity to degrade/dissolve, hydrophilic/hydrophobic change, hydrodynamic diameter, conformational change (globular/linear), micellisation, or change in water permeability. These changes can result in marked changes in F 2 , 112 q, 128 or τ m , 68 and thus T 1 contrast.
Such structural changes are, of course, markedly more useful if the responsive functional groups possess pK a values around physiological pHs (frequently employed groups which affect the hydration state q as a result of a response to a stimuli, include arylsulfonamide, 16 imidazole, 124 nitrophenol, 129 and phosphonate 125 ). Aime and co-workers have, for example, reported an adamantane derivative of a sulfonamide based Gd 3+ -chelate that was noncovalently hosted by a macromolecular carrier consisting of 8-10 poly-β-cyclodextrin units.
With a pK a of 6.7, the sulfonamide nitrogen deprotonates at basic pH and ligates to the metal centre, generating an "MRI silent" q = 0 state (a reversible change to q = 2 at acidic pH, 'turning on' relaxivity contrast). An additional integration into the same cyclodextrin scaffold of an adamantane functionalised 19 F-containing reporter can additionally engender ratiometric 1 H/ 19 F mapping of pH. 128 On the other hand, anionic, pH-sensitive polymers, such as those based on polymethacrylic acid (PMMA), can accept or release protons (Fig. 9) , resulting in swelling/contraction that modifies τ R . 112 At pH 7, a Gd 3+ -DO3A loaded spherical copolymer consisting of PMMA cross-linked by N,N′-methylenebisacrylamide becomes swollen due to electrostatic repulsion between the carboxy groups. At pH 4 carboxy group protonation induces the formation of a compact globule conformation of restricted molecular motion and r 1 increases from 13.6 mM −1 s −1 to 28.0 mM −1 s −1 . 107 The remarkably higher τ R of a generation-5 poly(amidoamine) (G5-PAMAM) dendrimer loaded with Gd 3+ -EPTPA in an acidic environment was studied in detail by Merbach and co-workers using the Lipari-Szabo approach to fit NMRD profiles. Under acidic conditions, repulsions between positively charged atoms associated with protonation of tertiary amines were increased, leading to an extended dendritic structure of slower global rotation (longer τ R due to increased τ RG = 4.04 ns) and increased hydrogen bond governed rigidity (F 2 = 0.43). The increases in τ RG and F 2 above those noted at basic pH (τ RG = 2.95 ns, F 2 = 0.36), generated relaxivity increases from 13.7 to 23.9 mM −1 s −1 at low pH. 90 The opposite effect of pH on τ R was reported for a macromolecular probe comprising 114 ornithine residues, 30 of which were linked to aminoethyl-functionalised Gd 3+ -DO3A through a squaric acid moiety. At acidic pH, cationic terminal amine side chains were highly hydrated and repelling, generating a highly flexible structure of low τ R and r 1 . At basic pH, deprotonation of the amine groups led to formation of a rigid α-helix structure, with an associated increase in r 1 to 32 mM −1 s −1 . 131 This behaviour was consistent with increasing τ R with pH as determined by NMRD. Above pH 7, the R 2 /R 1 ratio was independent of the local concentration of the paramagnetic agent allowing ratiometric imaging. 132 Both τ m and τ R contributed to responsiveness when 96 Gd 3+ -chelate moieties, each with four pH-sensitive phosphonate pendant arms that form hydrogen-bonds with bulk water (phosphonate triggered protic exchange in the second-hydration sphere 133 is described in Section 2.3), were covalently coupled to a G5-PAMAM dendrimer by the group of Sherry. At pH 9, r 1 (10.8 mM −1 s −1 ) was reportedly limited by slow water exchange. As the pH fell below 8.5, the phosphonates were consecutively protonated, and their effectiveness at catalysing proton exchange at Gd 3+ -coordinated H 2 O with bulk H 2 O increased. The combined effects of faster inner-sphere water exchange, longer τ m of the second sphere due to either a larger or more ordered second coordination shell (via protonated phosphonates), and longer τ R as a result of protonation of amines within the dendrimer, (turning on hydrogen bond mediated rigidification), 90 increase r 1 to 24.0 mM −1 s −1 at pH 6. However, the ultimate relaxivity here was limited by relatively slow water exchange in the innersphere (in the microsecond range) and by relatively fast protic exchange in the secondsphere (in the nanosecond range). 134 τ m and τ R have also been pH tuned through the loading of an amphiphilic Gd 3+ -DO3A derivative bearing a sulfonamide moiety into large unilamellar vesicles (LUV). Subsequent relaxivity decreases at high pH were ascribed not only to changes in inner-sphere hydration of the Gd 3+ -chelate (from q = 2 to q = 0), but also to its changed intraliposomal distribution and water exchange across the vesicle's membrane. In an acidic environment, protonation of the sulfonamide moiety with concomitant removal of the arm from the coordination cage of the Gd 3+ -ion caused its incorporation deeper into the liposomal membrane. As a result, the increased number of Gd 3+ -complexes intercalated into the membrane led to a higher τ R with respect to the free complex, an elongated τ m , an increased membrane permeability to water and consequently an enhanced relaxation rate R 1 . In a rather unusual step, the authors finally report that, in mapping the dependence of the ratio of the 1 H R 1 relaxation rates at two different magnetic fields (40 MHz and 8.5 MHz) on pH ( Fig. 10 ) ratiometric pH MR imaging can be achieved (image contrast independent of CA concentration). 135 There are, then, several different approaches which can be employed in the generation of high r 1 CAs with pH sensitive contrast. The most common approaches utilise either pH dependent swelling, causing variations in τ R , or pH dependent metal hydration/water exchange rate. In most cases, relatively modest (~2-fold) changes in relaxivity have been achieved to date. The potential within this field, however, is vast, with a range of disease states triggering notable variation in local pH profile. This is likely to be an area of active publishing in the coming years.
Redox-responsive particulate contrast agents
In comparison to pH, there are relatively few examples of particulate-based T 1 MRI probes for which contrast is tuned through a redox event. To date, examples are primarily based on changes in rotational correlation time. For example, the redox-responsive relaxivity change of a nanoparticulate MRI probe based on a thiol/disulfide redox couple is caused by variation in molecular dynamics (τ R ) as a result of degradation. Nanocapsules based on several β-CD units linked by disulfide bridges incorporated Gd 3+ -chelates that were able to interact with β-CD via hydrophobic pendant aromatic residues. The incorporated Gd 3+ -chelates exhibited high relaxivity (15.2 mM −1 s −1 at 70 MHz) due to restricted mobility and good water permeability through the β-CD shell. The addition of a reducing agent caused the nanocapsules to disassemble, releasing the β-CD monomers and Gd 3+ -complexes. As a result, τ R was shortened and relaxivity decreased to 8.2 mM −1 s −1 . 136 In comparable work but with converse observations, Liang and others obtained an enhanced relaxivity through elongated τ R as a consequence of self-assembly of gadolinium doped nanoparticles triggered by enzymatic and reductive cleavage. 137 After entry into cancer cells, the disulfide bond of an MRI contrast agent (r 1 = 6.0 mM −1 s −1 ) consisting of Gd 3+ -DOTA, 2-cyanobenzothiazole and a peptide sequence containing an S-S bond, was reduced by glutathione and the peptide sequence cleaved by furin, a trans-Golgi protease overexpressed in tumours. The so-generated intermediate Gd 3+ -complex condensed into an amphiphilic dimer with increased relaxivity (13.2 mM −1 s −1 ), self-assembling via π-π stacking into gadolinium containing nanoparticles, with τ R once again being responsible for contrast modulation. 138 These examples demonstrate that effective relaxation responses can be observed using a redox stimulus, although reductions in relaxivity resulting from dissolution are less useful from a potential toxicity perspective, increases due to lengthened τ R can provide >100% contrast signal enhancement.
Thermo-responsive particulate contrast agents
Temperature sensitive nanoparticulate MRI probes can potentially be used for both measuring temperature distribution in the human body, and thermometry, the latter largely Davies et al. Page 16 based on local hyperthermia for either chemodosimetry or controllably killing cancer cells. 123, 139, 140 In terms of CA relaxivity, work to date has focused on either temperature induced release of Gd 3+ -chelates from a liposomal core 140 or by a change in water access to particle internalised Gd 3+ -complexes. 141, 142 In both cases all prior work has been based on the transition of the liposomal phospholipid bilayer from a highly ordered gel-like phase that serves as a diffusion barrier to a fluid-like disordered state with increased membrane permeability (at T > T M ). 123 Grüll and others have, for example, investigated liposomes consisting of several different lipids including a thermoresponsive 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC, T M = 41.5 °C 140 ), and a lysolipid 1-palmitoyl-sn-glycero-3-phosphocholine (MPPC). T 1 measurements at T < T M imply that encapsulated Gd 3+ -complexes remain inside the aqueous lumen of the liposome so that relaxivity is limited by the water diffusion across the bilayer. This increases with increasing temperature, such that there is a sharp reduction in T 1 (from 1828 ms to 394 ms) above the T M , upon incubation of the liposomes at 45 °C for 30 min. 143 In vivo studies were performed by Li et al., who developed a DPPC-based thermo-sensitive liposomal formulation with encapsulated Gd 3+ -DTPA and doxorubicin. Chelate release was triggered by local hyperthermia and quantified by MRI. T 1 relaxation of a tumour in a BALB/c mouse treated by such liposomes was 2878 ms. After hyperthermic treatment in a hot bath at 43 °C, T 1 was accelerated to 1509 ms in the rim (i.e. 1-2 mm band around tumour periphery) and to 2482 ms in the core of the tumour due to Gd 3+ -DTPA release. 144 A two-point thermometry system with an "off-on" and "on-off" transition using lipid nanoparticles containing P(NIPAM)-co-P(AM) crosslinked with a Gd 3+ -chelate bi-linker was developed by Wu and others. 145 Poly(N-isopropylacrylamide) P(NIPAM) exhibits a unique temperature sensitivity, undergoing a reversible phase transition at 32 °C, expelling water and forming a contracted hydrophobic globule of low associated relaxivity. 146 The critical temperature of this transition could be raised with increasing amounts of copolymerised temperature insensitive monomer acrylamide (AM). At temperatures above the critical point the hydrophilic hydrogel containing the Gd 3+ -chelate crosslinker was exposed to water, increasing T 1 signal. 145 These investigations into the use of temperature activatable contrast agents exploiting tuneable interactions between bulk water and paramagnetic chelate have been successfully translated to in vivo studies and shown great promise, 144 particularly considering the demonstrable biocompatibility of the materials involved. Further analyses will undoubtedly present systems of greater control, tuneability and temperature definition.
Bio-responsive particulate contrast agents
Smart MRI nanoparticulate probes endeavour to sense molecular events, such as enzymatic activities and gene expression patterns at the level of the entire organism. 147 A number of attempts have been made to generate macromolecular contrast agents that respond significantly to the presence of a biomolecule of interest based on the so-called receptor-induced magnetisation-enhancement (RIME) effect. 148 In many cases this has been achieved through a modulation of τ R . Biotinylated DNA aptamers 3′ conjugated to Gd 3+ -DOTA have, for example, been observed to switch the terminal r 1 relaxivity by ~40% in the presence/absence of adenosine. This sensing occurs through binding induced changes in DNA hybridisation with its associated change in steric bulk. 149 Similarly, T 1 contrast of a G5-PAMAM dendrimer conjugated to folic acid and Gd 3+ -complex can be enhanced upon binding to a folate receptor due to resulting slower tumbling rates. 150 Similarly, the relaxivity of a gadolinium metallopeptide consisting of a DNA-binding transcription factor and a Ca 2+ -binding moiety increased r 1 by 100% to 42.4 mM −1 s −1 at 60 MHz upon binding to DNA, due to an increased τ R effect. 151 A τ R dependent relaxometric procedure was also developed by Aime and others, who exploited a ratiometric couple based on Gd 3+ -DOTA covalently linked to a peptide sequence and a lipophilic tail that was incorporated into a liposome (large R 2 /R 1 ). As the matrix metalloproteinase-2 cleaved the sequence between serine and leucine, the gadolinium complex was released from the liposomal membrane, and, due to increased τ R , R 2 /R 1 was reduced by ~46% at 300 MHz independent of the total concentration of gadolinium. 152 In addition, a Gd 3+ complex itself can be responsive to direct ligation to a biomolecule, whereby the number of inner sphere bound water molecules q changes upon binding. This conceptually and chemically simple mechanism has, for example, been demonstrated with an octahedral nanocage consisting of four rigid tridentate ligands coordinating six gadolinium atoms that showed a r 1 of 388.5 mM −1 s −1 , at 400 MHz. Addition of glucosamine triggered a decrease in r 1 to 62.1 mM −1 s −1 due to substitution of coordinated water molecules and decreased q (selectivity over glucose was notably observed). 110 Davis and co-workers have explored the first inorganic nanoparticle-based contrast system triggered by protein-protein recognition based on tuned water access and τ m (Fig. 11) . 111 They specifically reported the reversible contrast switching of Gd 3+ -chelate doped MSNs (r 1 = 15.1 ± 0.57 mM −1 s −1 at 300 MHz) by tuning the water access to internally biased paramagnetic centres (and thus k ex ) using a surface immobilised protein of sufficient steric bulk (in the protein gated state r 1 = 5.8 ± 0.22 mM −1 s −1 ). In the presence of a partner biomolecule (in this case a biotinylated protein), this steric cap was observed to be competed off, and both water access and high relaxivity were subsequently restored. This proof of principal serves to illustrate the significant potential of nanoparticle-based functional MR imaging in reporting on specific biorecognition processes.
The wide variety of potential bio-responsive triggers available which are associated with various disease and tumour states should stimulate further investigations into nanoparticle scaffolds, wherein both inherently high signal contrast and potentially dramatic contrast switching are possible.
Conclusions and future outlooks
There exist a plethora of MRI CAs which are capable of displaying strong positive or negative signals in vitro and in vivo. The prospect of CAs which can detect and respond to specific stimuli is an exciting one, with huge potential for non-invasive disease diagnosis and, more generally, the (potentially whole body) "mapping" of local biochemistry. This article has focused on T 1 paramagnetic centre-based contrast agents, and described some of the mechanisms which can be exploited to facilitate change in MRI contrast signal in response to a specific environmental trigger (see Table 1 ). Molecular, macromolecular and particulate-based contrast agents can, specifically, be engineered such that variations in hydration number (q), rotational correlation (τ R ) or water exchange (τ m ) follow specific chemical or physical interactions with their environment.
In general, macromolecular and particle-based CAs provide higher relaxivity values than molecular agents alone, due in part to significant lengthening of the paramagnet rotational correlation times through its association with a rigid, bulky, species. The degree of relaxivity modulation observed, however, is, thus far, similar for both molecular and nanoparticulate agents (see Table 1 ). As protocols for the synthesis of homogeneous and well-characterised particles become widely used, this area is likely to develop markedly over the next few years. Tactics to facilitate response are likely to involve designed switching of τ R and τ m , as well as gating water access to encapsulated paramagnetic centres. The possibility of utilising additional (native or added) multimodal characteristics (nuclear or otherwise), high local concentrations and targeting would make these agents exceedingly powerful from a diagnostic perspective.
To date, it is clear that the chemical complexities of an in vivo environment often prove detrimental in keeping image contrast switches both substantial and selective. The development of improved particle characterisation methodologies together with chemistries that introduce other magnetic nuclei, chemically exchangeable groups, or hyperpolarized centres, will, however, almost certainly underpin beneficial developments. [153] [154] [155] [156] [157] [158] Few areas of research have exploded quite as dramatically as the development of both molecular and nanoparticle based image contrast and therapeutic delivery systems during the past decade. Applying the chemists' toolkit and additionally integrating a non-invasive means of diagnosing and monitoring response to a treatment regime would, quite simply, herald a new age in clinical healthcare. Notes and references Schematic representation of inner, second and outer sphere water interaction with a typical T 1 contrast agent, a Gd-DOTA chelate. Illustration of the generic association between a Gd 3+ chelate (brown sphere) and a protein target (purple) resulting in lengthened τ R and improved MRI contrast. The carboxylic groups of anionic polymeric nanoparticulates are progressively deionised when exposed to an acidic environment resulting in polymer shrinking, restricted side chain mobility, and significantly increasing relaxivity. 107 The blue net represents the polymer and brown spheres the Gd 3+ -chelate groups covalently conjugated to polymer side chains. Schematic summary of the protein gating of MSNs. Externally biotinylated Gd-DOTA MSNs enjoy good water accessibility and a high relaxivity that can be reversibly capped by the steric bulk of bound streptavidin. In the presence of low μM of biotinylated BSA, the gating protein is competed off the particle surface and relaxivity recovers. Adapted from ref.
111 with permission from The Royal Society of Chemistry. 
